These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8613131)

  • 61. New drugs for aggressive B-cell and T-cell lymphomas.
    Murawski N; Pfreundschuh M
    Lancet Oncol; 2010 Nov; 11(11):1074-85. PubMed ID: 21051020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-Hodgkin's lymphoma presenting with prominent splenomegaly--clinicopathologic diversity in relationship to immunophenotype.
    Nair S; Shukla J; Chandy M
    Acta Oncol; 1997; 36(7):725-7. PubMed ID: 9490091
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel therapeutic agents for T-cell lymphomas.
    Chan TS; Kwong YL; Tse E
    Discov Med; 2013 Aug; 16(86):27-35. PubMed ID: 23911229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Very poor performance status elderly patients with aggressive B cell lymphomas can benefit from intensive chemotherapy.
    Bowcock SJ; Fontana V; Patrick HE
    Br J Haematol; 2012 May; 157(3):391-3. PubMed ID: 22188201
    [No Abstract]   [Full Text] [Related]  

  • 65. Primary T-cell rich B-cell lymphoma of the penis: a first case.
    Pomara G; Cuttano MG; Tripodo C; Carlino F; Selli C
    BJU Int; 2003 Jun; 91(9):889. PubMed ID: 12780856
    [No Abstract]   [Full Text] [Related]  

  • 66. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study.
    Kim YH; Lee JH; Yang SK; Kim TI; Kim JS; Kim HJ; Kim JI; Kim SW; Kim JO; Jung IK; Jung SA; Jung MK; Kim HS; Myung SJ; Kim WH; Rhee JC; Choi KY; Song IS; Hyun JH; Min YI
    Dig Dis Sci; 2005 Dec; 50(12):2243-7. PubMed ID: 16416168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Malignant lymphomas of the gastro-intestinal tract: a reappraisal on the basis of the newly proposed Revised European American Lymphoma Classification.
    Pileri S; Piccaluga PP; De Vivo A; Sabattini E; Poggi S; Melilli G; Falini B; Piccaluga A
    Ital J Gastroenterol; 1994; 26(8):405-18. PubMed ID: 7703515
    [No Abstract]   [Full Text] [Related]  

  • 68. Asynchronous bilateral non-Hodgkin's lymphoma of the testis: report of three cases.
    Selli C; Amorosi A; Nesi G; Bartoletti R; De Benedetto A; Cionini L
    Urology; 1994 Dec; 44(6):930-2. PubMed ID: 7985329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinicopathological characteristics of primary Ki-1 anaplastic large cell lymphoma.
    Kobayashi T; Nagasawa T; Mitsuhashi S; Hasegawa Y; Kojima H; Ninomiya H; Mori N; Abe T
    Int J Hematol; 1996 Jan; 63(1):41-50. PubMed ID: 8713576
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Primary lymphoma of the lung].
    Carvalho L; Silva TS
    Acta Med Port; 1995 Feb; 8(2):93-6. PubMed ID: 7771211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Malignant lymphoma can present as hepatobiliary disease.
    Harris AC; Ben-Ezra JM; Contos MJ; Kornstein MJ
    Cancer; 1996 Nov; 78(9):2011-9. PubMed ID: 8909324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overcoming the limitations of chemotherapy in the treatment of B-cell non-Hodgkin's lymphomas--an approach using radiolabeled peptide ligands.
    Renschler MF; Levy R
    West J Med; 1993 May; 158(5):530-2. PubMed ID: 8342278
    [No Abstract]   [Full Text] [Related]  

  • 73. Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature.
    Nishimura R; Takakuwa T; Hoshida Y; Tsujimoto M; Aozasa K
    Oncology; 2001; 60(4):322-9. PubMed ID: 11408800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemotherapy of non-Hodgkin's lymphomas.
    Cavalli F
    Baillieres Clin Haematol; 1991 Jan; 4(1):157-79. PubMed ID: 2039857
    [No Abstract]   [Full Text] [Related]  

  • 75. Discordant B- and T-cell non-Hodgkin's lymphoma: case report and review of literature.
    Reed D; Middlemas E; Gertsen E; Lamb MR
    Tenn Med; 2013; 106(10):35-7. PubMed ID: 24282837
    [No Abstract]   [Full Text] [Related]  

  • 76. [Must the immunologic T phenotype be examined as a prognostic factor for aggressive lymphomas?].
    Gisselbrecht C
    Pathol Biol (Paris); 1993 Jan; 41(1):94-5. PubMed ID: 8316489
    [No Abstract]   [Full Text] [Related]  

  • 77. T-cell-rich B-cell lymphoma.
    Rodriguez J; Pugh WC; Cabanillas F
    Blood; 1993 Sep; 82(5):1586-9. PubMed ID: 8364208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transformation to aggressive B-cell lymphoma: morphology, immunophenotype, and molecular characteristics.
    Said J
    Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):199-205. PubMed ID: 12966345
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The ultrastructure of signet-ring cell non-Hodgkin's lymphoma.
    Eyden BP; Cross PA; Harris M
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(5):395-404. PubMed ID: 2122586
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel treatments for T-cell lymphoma.
    Cheah CY; Oki Y; Fanale MA
    Am Soc Clin Oncol Educ Book; 2015; ():e468-78. PubMed ID: 25993211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.